Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost–effectiveness
✍ Scribed by Keith, Samuel
- Book ID
- 125492165
- Publisher
- Expert Reviews
- Year
- 2009
- Tongue
- English
- Weight
- 605 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1473-7175
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi
## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or